Commentary: Tumor associated neutrophils promote prostate cancer progression by mediating neutrophil trap secretion through PSMA1- NF-κB-HIF-1α signaling axis 27 de August de 2026 by Yiling Qin
Commentary: Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1–3a follicular lymphoma 26 de August de 2026 by Guilan Cheng
Commentary: Bibliometric and visual analysis in the field of macrophages in Traditional Chinese Medicine from 2003 to 2023 12 de August de 2026 by Ge Zhu
Commentary: Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation 4 de August de 2026 by Qingyu Wan
Commentary: Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis 3 de August de 2026 by Hui Liu
General Commentary: From hospital exemption to evidence: a statistical framework for leveraging real-world data 31 de July de 2026 by Gloria Brigiari
Commentary: Immunometabolic control of cytokine production by micronutrients in health, aging, and inflammation 28 de July de 2026 by ZhiTong Qu
Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence 17 de July de 2026 by Hai-Hong Lin
Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities 15 de July de 2026 by Lidetian Hu
Commentary: PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway 3 de July de 2026 by Wujie Chen
